HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lauder In-House Counsel: Start Planning For Supply Chain Quality Agreements Under MoCRA

Executive Summary

Companies that have struggled to secure quality agreements with suppliers have additional leverage and a new starting point for those discussions, namely the Modernization of Cosmetic Regulations Act. Anand Natarajan, associate counsel at The Estee Lauder Companies, provided his view in a recent FDLI webinar.

You may also be interested in...

US FDA Seeks Input On Cosmetics GMP Development, Industry Costs, Likely Safety Impacts

The agency is accepting comments from 27 April to 3 July 2023 to Docket No. FDA-2023-N-1466 to inform its development of good manufacturing practices for facilities that manufacture or process cosmetic products distributed in the United States. A virtual “listening session” is slated for 1 June.

Getting A Jump On MoCRA Compliance; Due Diligence Now Will Lighten Load, Risks Later

Cosmetics companies should not sit idly waiting for FDA to clarify new requirements under the Modernization of Cosmetic Regulations Act, speakers agreed at the Independent Beauty Association’s 2023 Technical/Regulatory Forum. Companies should be reviewing products, people and processes, including those of contract manufacturers, to get ahead of the curve.

NSF Leaders On How New Cosmetics Certification Could Bolster MoCRA Compliance

NSF’s Contents and Claims Certified Guideline for beauty and personal-care products should position companies well for compliance with new US regulations under the Modernization of Cosmetic Regulations Act, the organization says. NSF senior leaders discuss in an interview with HBW Insight.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts